HLA-DRB1 and rheumatoid arthritis: The ability of oxPTM-CII to interact with HLA-DRB1*04 may activate autoreactive T-cells or B-cells, as observed in RA, suggesting a possible cross-reactive mechanism in a subset of T1D patients.